Responses from pharmaceutical companies to doctors' requests for more drug information in Pakistan: Postal survey

British Medical Journal

Volumn 319, Issue 7209, 1999, Pages 547-

  Hafeez, Assad ^a   Mirza, Zafar ^b  

^a Khan Research Labs General Hospital   (Pakistan)

^b Netwk for Rational Use of M   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG INDUSTRY; DRUG INFORMATION; GOVERNMENT; HUMAN; MEDICAL SPECIALIST; PAKISTAN; PHYSICIAN; POLICY; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0033612863     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.319.7209.547     Document Type: Article

References (5)

1. 1 Avorn J, Chen M, Hertley R. Scientific: versus commercial sources of influence on the prescribing behavior of physicians. Am J Med 1987;73: 4-8.
2. 2 Lexchin J. Pharmaceutical promotion in Canada: convince them or confuse them. Int J Health Serv 1987;17:77-89.
3. 3 World Health Organisation. Ethical criteria for medicinal drug promotion. Geneva: WHO, 1988.
4. 4 Lexchin J. Pharmaceutical promotion in the third world. J Drug Issues 1992;22:417-37.
5. 5 Dikshit RK, Dikshit N. What information is available on request from drag advertisers in India? BMJ 1996;313:855-6.